The FDA has approved use of GlaxoSmithKline’s Boostrix (Tdap) vaccine for use during the third trimester of pregnancy, for prevention of pertussis (whooping cough) in infants younger than two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback